Lifecore Biomedical Inc (LFCR)
5.69
-0.14
(-2.40%)
USD |
NASDAQ |
May 23, 16:00
5.68
-0.01
(-0.18%)
Pre-Market: 20:00
Lifecore Biomedical Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 256.37M |
| May 22, 2024 | 260.64M |
| May 21, 2024 | 264.61M |
| May 20, 2024 | 263.85M |
| May 17, 2024 | 261.86M |
| May 16, 2024 | 258.81M |
| May 15, 2024 | 265.53M |
| May 14, 2024 | 269.50M |
| May 13, 2024 | 269.20M |
| May 10, 2024 | 274.39M |
| May 09, 2024 | 283.25M |
| May 08, 2024 | 285.69M |
| May 07, 2024 | 292.41M |
| May 06, 2024 | 286.00M |
| May 03, 2024 | 277.75M |
| May 02, 2024 | 276.53M |
| May 01, 2024 | 279.28M |
| April 30, 2024 | 278.67M |
| April 29, 2024 | 279.89M |
| April 26, 2024 | 284.01M |
| April 25, 2024 | 285.39M |
| April 24, 2024 | 275.92M |
| April 23, 2024 | 279.58M |
| April 22, 2024 | 274.69M |
| April 19, 2024 | 286.91M |
| Date | Value |
|---|---|
| April 18, 2024 | 275.46M |
| April 17, 2024 | 282.03M |
| April 16, 2024 | 282.33M |
| April 15, 2024 | 273.47M |
| April 12, 2024 | 267.67M |
| April 11, 2024 | 271.03M |
| April 10, 2024 | 261.25M |
| April 09, 2024 | 270.42M |
| April 08, 2024 | 266.14M |
| April 05, 2024 | 270.11M |
| April 04, 2024 | 269.50M |
| April 03, 2024 | 270.42M |
| April 02, 2024 | 251.17M |
| April 01, 2024 | 259.42M |
| March 28, 2024 | 244.76M |
| March 27, 2024 | 240.48M |
| March 26, 2024 | 240.18M |
| March 25, 2024 | 247.51M |
| March 22, 2024 | 241.09M |
| March 21, 2024 | 236.51M |
| March 20, 2024 | 235.59M |
| March 19, 2024 | 302.19M |
| March 18, 2024 | 301.88M |
| March 15, 2024 | 307.99M |
| March 14, 2024 | 309.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
162.65M
Minimum
Mar 17 2023
567.62M
Maximum
Jun 07 2021
419.75M
Average
444.42M
Median
Mar 17 2020
Enterprise Value Benchmarks
| Aquestive Therapeutics Inc | 213.07M |
| SELLAS Life Sciences Group Inc | 59.55M |
| ADMA Biologics Inc | 2.281B |
| Relmada Therapeutics Inc | 10.23M |
| Jaguar Health Inc | 45.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.13M |
| Revenue (Quarterly) | 31.55M |
| Total Expenses (Quarterly) | 36.96M |
| EPS Diluted (Quarterly) | -1.19 |